Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca Pharma India Ltd. AGM Information 2021

Aug 9, 2021

60656_rns_2021-08-09_89b85018-7fbb-425d-95c8-2e12c7b93c07.pdf

AGM Information

Open in viewer

Opens in your device viewer

AstraZeneca4

==> picture [103 x 95] intentionally omitted <==

----- Start of picture text ----- Bringing selfflte tG patients since 19714a----- End of picture text -----

August 9, 2021

The Manager- Listing BSE Limited Corporate Relationship Dept., 5[th ] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai - 400001

National Stock Exchange of India Limited Exchange plaza, 5[th ] Floor, Plot No.C/1, G Block Bandra -Kurla Complex, Bandra (E), Mumbai - 400051

Dear Sir,

Sub: Summary of Proceedings of 42[nd ] Annual General Meeting Ref: Scrip code -BSE: 506820, NSE: ASTRAZEN

Pursuant to the provisions of Regulation 30 read with Part A of Schedule III to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the following business were transacted at the 42 [nd ] Annual General Meeting (AGM) of the Company held on August 9, 2021 at 3.00 P.M. through Video Conferencing/Other Audio Visual Means:

  1. Adoption of Financial Statements for the financial year ended March 31, 2021 and the Reports of the Board of Directors and Auditors thereon.

  2. Confirmation of the payment of interim dividend of Re. 2/- per Equity Share for the financial year 2020-21.

  3. Appointment of Mr. Ankush Nandra (DIN: 08737981), Non-Executive Director who retires by rotation, and being eligible, offers herself for re- appointment.

  4. Re-appointment of Price Waterhouse & Co. Chartered Accountants, LLP as the statutory auditors of the Company, for a second term of 5 years, to hold from the conclusion of 42 [nd ] Annual General Meeting till the conclusion of the 4 7 [th ] Annual General Meeting.

  5. Re-appointment of Ms. Revathy Ashok (00057539) as an Independent Director of the Company for a second term of 5 years w.e.f. December 2, 2021 to December 1, 2026.

==> picture [71 x 70] intentionally omitted <==

  1. Ratification of Cost Auditor's remuneration.

CORPORATE & REGO. OFFICE TEL : +91 80 6774 8000 FACTORY TEL : +91 80 6774 9000 AstraZeneca Pharma India Ltd. 12th Mile on Bellary Road FAX : +91806774 8857 P. B. No. 4525, Block N1, 12th Floor, Venkatala, Kattigenahalli Village FAX : +91 80 2846 2208 Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, CIN : L24231KA1979PLC003563 Yelahanka Bangalore - 560 063 +91 80 6774 9628 Bangalore - 560 045, INDIA WEB : www.astra,:eneca.com/india INDIA

AstraZeneca4

==> picture [103 x 95] intentionally omitted <==

----- Start of picture text ----- 4Brtnglng stlent 1 pent stnc 19a----- End of picture text -----

Kindly note that voting results will be announced upon the receipt of Scrutinizer's Report and will be submitted as per Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Please take same on record.

==> picture [198 x 83] intentionally omitted <==

TEL : +91806774 sooo FAX : +91 80 6774 8857 CIN : L24231KA1979PLC003563 WEB : www.astrazeneca.com/india

FACTORY

TEL : +91 80 6774 9000

12th Mile on Bellary Road Venkatara, Kattigenahalli Village Yelahanka FAX : +91 80 2846 220a Bangalore - 560 063 +91 80 677 4 9628 INDlA

CORPORATE & REGD. OFFICE AstraZeneca Pharma India Ltd. P. B. No. 4525, Block N1, 12th Floor, Manyata Embassy Business Park. Rachenahalli, Outer Ring Road, Bangalore - 560 045, INDIA